To save lives, the FDA must change how it evaluates rare disease treatments
For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients
Source: yahoo.com
📰 Mark Dant News
Mark Dant News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Dant. Real-time updates on events, politics, business and more.